Sanders Morris Harris’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Sanders Morris Harris’s Portfolio GBT Stock Details GBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-6,500	Closed	-$444K	–	298
2022 Q3	$444K	Hold	6,500	–	–	0.11%	150
2022 Q2	$213K	Sell	6,500 -6,500	-50%	-$190K	0.05%	249
2022 Q1	$450K	Buy	+13,000	New	+$389K	0.09%	179
2021 Q3	–	Sell	-6,750	Closed	-$226K	–	338
2021 Q2	$226K	Hold	6,750	–	–	0.04%	277
2021 Q1	$285K	Hold	6,750	–	–	0.06%	236
2020 Q4	$330K	Hold	6,750	–	–	0.08%	213
2020 Q3	$408K	Buy	+6,750	New	+$429K	0.11%	170

Other funds holding GBT

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Sanders Morris Harris's GBT Position: Q4 2022 in Review

Sanders Morris Harris sold out of Global Blood Therapeutics, Inc. (GBT) in Q4 2022, closing a stake of 6,500 shares — an estimated $444K sold.

Sanders Morris Harris first reported a position in GBT in Q3 2020 and held it in 7 quarters. The position peaked at $450K in Q1 2022. 2 funds tracked by Wall St. Rank hold GBT as of Q4 2022.

Sanders Morris Harris reported no remaining Global Blood Therapeutics, Inc. position as of Q4 2022 after selling out during the quarter.
Sanders Morris Harris sold 6,500 Global Blood Therapeutics, Inc. shares in Q4 2022, an estimated $444K.
Sanders Morris Harris first reported a position in Global Blood Therapeutics, Inc. in Q3 2020 and held it in 7 quarters.
Sanders Morris Harris's Global Blood Therapeutics, Inc. position peaked at $450K in Q1 2022.
2 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q4 2022.

Based on Sanders Morris Harris's 13F filing for Q4 2022, filed 13 Jan 2023.